vs
Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and Valneva SE (VALN). Click either name above to swap in a different company.
COLONY BANKCORP INC is the larger business by last-quarter revenue ($39.9M vs $36.2M, roughly 1.1× Valneva SE). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -54.1%, a 74.7% gap on every dollar of revenue.
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
CBAN vs VALN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $36.2M |
| Net Profit | $8.2M | $-19.6M |
| Gross Margin | — | 38.9% |
| Operating Margin | — | -49.5% |
| Net Margin | 20.6% | -54.1% |
| Revenue YoY | — | — |
| Net Profit YoY | 24.1% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $39.9M | — | ||
| Q4 25 | $36.9M | — | ||
| Q3 25 | $32.8M | — | ||
| Q2 25 | $32.5M | — | ||
| Q1 25 | $30.0M | — | ||
| Q4 24 | $30.8M | — | ||
| Q3 24 | $28.6M | — | ||
| Q2 24 | $27.9M | — |
| Q1 26 | $8.2M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $5.8M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $6.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $5.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 25.9% | — | ||
| Q3 25 | 22.2% | — | ||
| Q2 25 | 30.9% | — | ||
| Q1 25 | 27.6% | — | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | 24.8% | — |
| Q1 26 | 20.6% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 24.6% | — | ||
| Q1 25 | 22.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 19.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | — | ||
| Q3 25 | $0.33 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.38 | — | ||
| Q4 24 | $0.43 | — | ||
| Q3 24 | $0.32 | — | ||
| Q2 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $295.8M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $380.4M | $221.2M |
| Total Assets | $3.7B | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $258.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $248.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $380.4M | — | ||
| Q4 25 | $375.9M | — | ||
| Q3 25 | $302.3M | — | ||
| Q2 25 | $293.9M | — | ||
| Q1 25 | $286.9M | — | ||
| Q4 24 | $278.7M | — | ||
| Q3 24 | $276.1M | — | ||
| Q2 24 | $264.7M | — |
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-26.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $14.4M | — | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $17.9M | — | ||
| Q4 24 | $23.4M | — | ||
| Q3 24 | $20.5M | — | ||
| Q2 24 | $1.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-6.9M | — | ||
| Q3 25 | $14.1M | — | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $17.6M | — | ||
| Q4 24 | $22.3M | — | ||
| Q3 24 | $20.2M | — | ||
| Q2 24 | $990.0K | — |
| Q1 26 | — | — | ||
| Q4 25 | -18.7% | — | ||
| Q3 25 | 42.9% | — | ||
| Q2 25 | 48.5% | — | ||
| Q1 25 | 58.7% | — | ||
| Q4 24 | 72.5% | — | ||
| Q3 24 | 70.6% | — | ||
| Q2 24 | 3.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.48× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.64× | — | ||
| Q2 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
VALN
Segment breakdown not available.
